Resources

Past Presentation

Initial Therapy: Methotrexate | November 6, 2023

Date of Presentation: November 6, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Rheumatoid Arthritis  

Keywords: #arthritis  #dmard  #methotrexate  #mtx  #ra  #rheumatoid  

In this presentation, Dr. Jennifer Mandal provides a comprehensive overview of methotrexate, the preferred first-line Disease Modifying Anti-Rheumatic Drug (DMARD) for moderate-severe Rheumatoid Arthritis (RA).

Recording:

Presented by:

Dr. Jennifer Mandal, MD

Dr. Jennifer Mandal, MD is an Assistant Professor of Medicine at UCSF, the UCSF School of Medicine Lead for Interprofessional Education, and the Director of Evaluation for the UCSF Rheumatology Fellowship Program. Her clinical work focuses on the care of vulnerable patients with severe RA at the Rheumatoid Arthritis Clinic at Zuckerberg San Francisco General Hospital.

She has more than a decade of experience in medical education, including curriculum development, evaluation and assessment, interprofessional education research, and simulation, and has received national recognition as a leader in interprofessional health education and research. Her education research has been published in peer reviewed journals and presented nationally and internationally. Her primary interest is in utilizing novel education techniques to promote interprofessional collaboration and improve access to rheumatology care.

Resources Provided:

Date added: November 5, 2023